Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesotherapy added to PRP in Knee Osteoarthritis
NCT05329116Unknown
- Start
- May 2022
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of pentoxifylline and lidocaine in osteoarthritis (OA) (2 arms). Primary endpoint: Visual Analogue Scale at 3 months. Status: unknown.
02
Drugs
pentoxifyllinelidocaine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05329116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05329116.